1Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2006[J]. CA Cancer J Clin, 2006, 56(2) : 106 -130.
2Ward J F,Slezak J M,Blute M L, et al. Radical prostatectomy for clinically advanced (cT3) prostate cancer since the advent of prostate-specific antigen testing 15 year outcome[J].BJU Int, 2005, 95(6): 751- 756.
3Carver B S,Bianco F J Jr, Scardino P T, et al. Long-term out come following radical prostatectomy in men with clinical stage T3 prostate cancer[J]. J Urol,2006, 176(2): 564-568.
4Freedland S J, Partin A W, Humphreys E B, et al. Radical Prostatectomy for Clinical Stage T3a Disease[J]. Cancer, 2007,109(7) 1273-1278.
5Hill J R, Fine S W, Zhang J, et al. Radical prostatcctomy for clinical T3 disease: expanding indications while optimizing cancer control and quality of life. Nat[J]. Clin Pract Urol,2007,4(8): 451-454.
6Musch M, Klevecka V, Roggenbuck U, et al. Complications of pelvic lymphadenectomy in 1, 380 patients undergoing radical retropubic prostatectorny between 1993 and 2006[J].J Urol, 2008,179(3) :923-928.
7Martinez-Salamanca J I, Rornero Otero J. Critical comparative a nalysis between open, laparoscopic and robotic radical prostatec tomy: perioperative morbidity and oncological results (Part I) [J]. Arch Esp Urol,2007, 60(7) :755- 765.
8Joseph L,Chin, Patrick P. Luke, et al. Initial experience with robotic assisted laparoscopie radical prostatectomy in the Canadian heahh care system[J]. CUAJ,2007,1(2): 97 -101.
9Pilepich M V, Winter K, I.awton C A, et al. Androgen suppression adjuvant to definitive radiotherapy in prostate carcino malong term results of Phase Ⅲ RTOG 85 -31[J]. Int J Radial Oncol Biol phys, 2005, 61(5):1285 -1290.
10Slater J D, Rossi C J, Yonemoto IJ T, et al. Proton therapy for prostate cancer: The initial l.oma Linda University experience [J].Int J Radiat Oncol Biol Phys, 2004,59(2):348-352.
